Bipolar II disorder consists of recurring episodes of depression and hypomania, a milder form of mania . In the long run, spending patients with bipolar I disorder, three times longer in the depressed state than in mania. Patients with bipolar II disorder have traditionally been difficult to treat, as they spend almost 40 times longer in the depressed state than in mania . Without adequate treatment, patients often suffer life-long interrupted with periods of wellness and functioning of serious consequences of the disease.
For a discussion of such risks and uncertainties, see the Company’s Annual Report / Form 20-F for the year 2004.. For more information about AstraZeneca, please visit:This press release contains forward-looking statements with respect to AstraZeneca’s business. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances in the future. In the future. Continue reading